While radiologists are trained experts in detecting breast cancer, certain types of tumors are still difficult to detect due to their elusive nature.

Join us for a compelling discussion with Dr. Laura Dean, a renowned breast radiologist at the Cleveland Clinic, who will share how iCAD’s ProFound AI Suite is elevating radiologist performance and enhancing patient care at the Cleveland Clinic. Discover how Dr. Dean is leveraging iCAD’s market-leading technology to detect breast cancers, including small, subtle tumors – the types of cancers radiologists fear the most.

"Even for experienced radiologists, some findings are so subtle they can be difficult to detect. ProFound AI acts as an extra set of eyes that empowers our team to catch even the smallest, most difficult to detect cancers – and with greater accuracy than ever. This reliable, game-changing technology not only improves our confidence, it optimizes efficiency and improves patient outcomes." – Laura H. Dean, MD, Radiologist, Section of Breast Imaging, Cleveland Clinic

Laura H. Dean, MD
Radiologist, Section of Breast Imaging, Cleveland Clinic

Dana Brown
President and CEO of iCAD, Inc. (Moderator)

Mikael Eriksson, PhD
Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Per Hall, MD, PhD
Professor/Senior Physician, Karolinska Institutet and Södersjukhuset, Stockholm, Sweden

Register for Webinar